Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
December 10, 2013
Knockdown strategies for the study of proprotein convertases and proliferation in prostate cancer cells
François D'Anjou, Frédéric Couture, Roxane Desjardins, et al.
Canadian Journal of Physiology and Pharmacology
|
March 3, 2020
Upregulation of PACE4 in prostate cancer is not dependent on E2F transcription factors
Anita Bakrania, Mélanie Aubé, Roxane Desjardins, et al.
Neoplasia (New York, N.Y.)
|
December 11, 2012
Role of proprotein convertases in prostate cancer progression
Frédéric Couture, François D'Anjou, Roxane Desjardins, et al.
The Journal of Biological Chemistry
|
October 21, 2016
An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells
Kévin Ly, Rachid Essalmani, Roxane Desjardins, et al.
Endocrinology
|
October 25, 2003
Biosynthesis of proopiomelanocortin-derived peptides in prohormone convertase 2 and 7B2 null mice
Virginie Laurent, Lisa Jaubert-Miazza, Roxane Desjardins, et al.
Plos One
|
May 3, 2013
Proprotein convertase 1/3 (PC1/3) in the rat alveolar macrophage cell line NR8383: localization, trafficking and effects on cytokine secretion
Hugo Gagnon, Sarah Refaie, Sandra Gagnon, et al.
European Journal of Cell Biology
|
March 29, 2017
PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression
François Panet, Frédéric Couture, Anna Kwiatkowska, et al.
Journal of Medicinal Chemistry
|
September 6, 2018
Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines
Vahid Dianati, Anna Kwiatkowska, Frédéric Couture, et al.
The Journal of Endocrinology
|
March 3, 2007
Strain-specific steroidal control of pituitary function
Sang-Nam Lee, Bonnie Peng, Roxane Desjardins, et al.
Scientific Reports
|
October 19, 2022
Efficacy of PACE4 pharmacotherapy in JHU-LNCaP-SM preclinical model of androgen independent prostate cancer
Nawel Mekdad, Thi Minh Hue Tran, Roxane Desjardins, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Methods in Molecular Biology (Clifton, N.J.)
|
December 10, 2013
Knockdown strategies for the study of proprotein convertases and proliferation in prostate cancer cells
François D'Anjou, Frédéric Couture, Roxane Desjardins, et al.
Canadian Journal of Physiology and Pharmacology
|
March 3, 2020
Upregulation of PACE4 in prostate cancer is not dependent on E2F transcription factors
Anita Bakrania, Mélanie Aubé, Roxane Desjardins, et al.
Neoplasia (New York, N.Y.)
|
December 11, 2012
Role of proprotein convertases in prostate cancer progression
Frédéric Couture, François D'Anjou, Roxane Desjardins, et al.
The Journal of Biological Chemistry
|
October 21, 2016
An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells
Kévin Ly, Rachid Essalmani, Roxane Desjardins, et al.
Endocrinology
|
October 25, 2003
Biosynthesis of proopiomelanocortin-derived peptides in prohormone convertase 2 and 7B2 null mice
Virginie Laurent, Lisa Jaubert-Miazza, Roxane Desjardins, et al.
Plos One
|
May 3, 2013
Proprotein convertase 1/3 (PC1/3) in the rat alveolar macrophage cell line NR8383: localization, trafficking and effects on cytokine secretion
Hugo Gagnon, Sarah Refaie, Sandra Gagnon, et al.
European Journal of Cell Biology
|
March 29, 2017
PACE4 is an important driver of ZR-75-1 estrogen receptor-positive breast cancer proliferation and tumor progression
François Panet, Frédéric Couture, Anna Kwiatkowska, et al.
Journal of Medicinal Chemistry
|
September 6, 2018
Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines
Vahid Dianati, Anna Kwiatkowska, Frédéric Couture, et al.
The Journal of Endocrinology
|
March 3, 2007
Strain-specific steroidal control of pituitary function
Sang-Nam Lee, Bonnie Peng, Roxane Desjardins, et al.
Scientific Reports
|
October 19, 2022
Efficacy of PACE4 pharmacotherapy in JHU-LNCaP-SM preclinical model of androgen independent prostate cancer
Nawel Mekdad, Thi Minh Hue Tran, Roxane Desjardins, et al.
Page
of 4